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Background & Aims: The importance of expression of interferon gamma-inducible protein of 10 kilodaltons (IP-10, CXCL10) during chronic hepatitis B virus (HBV) infection has been recently emphasized. In this report, we investigated whether the naturally occurred sequence variations in the CXCL10 gene impact liver damage and disease progression of chronic HBV infection. Methods: A hospital-based case-control study was conducted, and a total of 613 and 1787 unrelated Han Chinese HBV carriers were recruited from Beijing and Chongqing, respectively. We systematically screened sequence variations in the CXCL10 gene and examined the association between the variations in this gene and susceptibility to disease progression of chronic HBV infection in Chinese populations from Beijing and Chongqing. Functional analyses were conducted to verify the biological significances of the associated genetic variation. Results: We identified that the polymorphism G-201A, located in the promoter region of CXCL10, was associated with susceptibility to disease progression in male HBV carriers (dominant model; odds ratio, 1.53; P ‫؍‬ .001). Functional analyses show that the G-201A polymorphism alters the binding affinity of nuclear protein and regulates CXCL10 expression. We observed higher CXCL10 transcription in interferon gamma-stimulated peripheral blood mononuclear cells with the diseasesusceptible genotypes. Enzyme-linked immunosorbent assay and immunohistochemical analysis showed augmented CXCL10 production in serum and liver tissues of progressed HBV carriers. Conclusions: The novel regulatory polymorphism G-210A in the promoter of CXCL10 gene could be a part of the genetic variation underlying the susceptibility of individuals to disease progression of chronic HBV infection.
H epatitis B virus (HBV) is the most common cause of acute and chronic liver diseases worldwide, especially in several areas of Asia and Africa. 1, 2 For subjects who are infected with HBV during early childhood, liver damage occurs mainly during the immune clearance phase. 3, 4 During chronic HBV infection, the HBV-specific CD8 T-cell response, in the absence of viral clearance, may contribute to both liver cell damage and the recruitment of non-virus-specific T cells. 5 Such recruitment of non-antigen-specific CD4/CD8 cells mediated by interferon (IFN)-␥ has been shown in HBV surface antigen (HBsAg) transgenic mice with fulminant hepatitis 6 and in the incubation phase of acute hepatitis B in humans. 7 Two studies have identified that the IFN-␥-inducible protein of 10 kilodaltons (IP-10), also named as chemokine (C-X-C motif) ligand 10 (CXCL10), is a response gene induced in the livers of HBV transgenic mice 8 and chimpanzees acutely infected with HBV. 9 CXCL10 chemoattracts activated T lymphocytes and natural killer cells by binding to chemokine (C-X-C motif) receptor 3 (CXCR3), a G protein-coupled receptor. 10, 11 Recent reports have also shown that CXCL10 was expressed in the liver of patients with chronic hepatitis B; its expression on the transcription level was higher than those with liver disorders unrelated to viral infections but lower than those with chronic hepatitis C. 12 Harvey et al 13 showed that CXCL10 could be induced within hepatocytes in liver tissue, and its expression correlated with histologic severity and lobular inflammation in patients with chronic hepatitis C virus infection. However, the role of CXCL10 in the progression of patients with chronic HBV infection has not been well established.
Because CXCL10 seems to be important for the intrahepatic recruitment, antiviral effect, and pathogenetic effect of HBV-specific cytotoxic T lymphocytes and/or other nonspecific inflammatory cells during chronic HBV infection, it is expected that the naturally occurring sequence variations in the CXCL10 gene may result in altered expression and/or binding ability of the CXCL10 protein, thereby impacting liver damage and disease progression of patients with chronic HBV infection. In this report, we systematically screened sequence variations in the CXCL10 gene and then examined the association between the variations in this gene and susceptibility to disease progression of chronic HBV infection in Chinese populations.
Materials and Methods

Study Participants
A total of 2400 unrelated Han Chinese HBV carriers were recruited at Infectious Disease Hospital (Beijing, China) and Southwest Hospital (Chongqing, China) between February 2001 and March 2006 (613 carriers were from Beijing and 1787 from Chongqing). All HBV carriers were positive for both HBsAg and antibody to HBV core antigen of the immunoglobulin G type for at least 12 months. All carriers were measured with liver function tests, serum immunologic marker screening, and liver ultrasonography/computed tomography imaging, and 376 (15.7%) were examined with histologic biopsy. All carriers had no serologic evidence for coinfection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus.
Among the 2400 HBV carriers, 1147 progressed carriers and 1253 nonprogressed carriers were included, among which 312 patients with liver cirrhosis and 415 nonprogressed carriers were described in detail in our previous study. 14 The nonprogressed carriers had normal serum levels of alanine aminotransferase, aspartate aminotransferase, and total bilirubin throughout the study, without any evidence for liver image/histologic change and previous history of hepatitis B. The progressed carriers were HBsAg positive, with severe hepatitis, liver cirrhosis, or hepatocellular carcinoma. Of the 1147 progressed carriers, 241 individuals were patients with severe hepatitis B who had serum total bilirubin levels Ͼ10 times the upper limit of normal without evidence for liver cirrhosis; among them, 185 (76.8%) were patients with acute liver failure (prothrombin index Ͻ40%, with an illness of Ͻ24 weeks' duration); 673 were patients with liver cirrhosis who were diagnosed with positive ultrasonography/computed tomography imaging or histopathologic findings on examination of liver tissue; and 233 were subjects with hepatocellular carcinoma based on positive findings on cytologic or pathologic examination and/or positive images on angiography/ultrasonography/computed tomography solely or combined and/or a serum ␣fetoprotein level Ͼ400 ng/mL.
The normal control population consisted of 568 unrelated healthy Han Chinese (79.4% male; mean age, 34.4 Ϯ 12.1 years) recruited from Beijing Blood Donor Centers (n ϭ 253) and Southwest Hospital (n ϭ 315) who were naive to HBV, with all HBV serum markers negative.
All subjects provided informed consent to participate in the study, as approved by the ethical committee of the Chinese Human Genome, Beijing.
Discovery of Single Nucleotide Polymorphisms and Determination of Haplotype-Tagged Single Nucleotide Polymorphisms
Single nucleotide polymorphism (SNP) screening of the approximately 4.2-kilobase region of CXCL10 (re- ferred to as GenBank accession no. NT_016354.16), continuously from the 5= flanking to 3= flanking genomic region (including all exons, relevant exon-intron boundaries, and ϳ1.8-kilobase promoter region; see Figure 1 ), was performed with 11 pairs of overlapping primer sets (the primer sequences are listed in Supplementary Table 1 ; see supplemental material online at www.gastrojournal. org) by polymerase chain reaction (PCR) direct sequencing as described previously. 14, 15 SNP candidates were identified by the PolyPhred program and inspected by 2 observers. SNP positions and individual genotypes have been confirmed by reamplifying and resequencing the SNP site from the opposite strand. The screening panel included 27 unrelated individuals randomly selected from the 2400 HBV carriers regardless of disease status. The sample size gave us 95% probability of detecting alleles with a minimal frequency of 5.4%. 16 CXCL10 haplotypes from the unrelated Chinese samples were assigned by the PHASE program. 17 Program htSNP2 (Wellcome Trust, Cambridge, England) was used to determine the haplotype-tagged SNPs (htSNPs) as described previously. 18 The pairwise linkage disequilibrium (LD) measures were calculated using the Arlequin package (University of Geneva, Geneva, Switzerland). The values of pairwise D= and r 2 were plotted using the LDA program. 19 
Genotyping
We extracted genomic DNA from peripheral blood leukocytes of 5 mL whole blood using standard phenol/ chloroform protocols. DNA samples were diluted to 8 ng/L and distributed to 96-well plates (DNA panels), each of which contained 94 samples and 2 DNA-free control water.
Two htSNPs, G-201A and C-1513T polymorphisms in the 5= flanking region of the CXCL10 gene, were selected for genotyping in the study population using PCR/restriction fragment length polymorphism analysis. An amplification using forward primer 5=-GCAGATACTGTCTCAGAACCT-GGTA-3= and reverse primer 5=-TGTCACCATCTCT-CATTTTGATTGT-3= was performed with an annealing temperature of 57°C. The reaction yielded a 499 -base pair amplicon. PCR products of 3 L were digested with 4 U of XbaI and 4 U SacI (Takara BioTech, Dalian, China) for the C-1596T and the C-1513T polymorphisms, respectively. The homozygotes with -1596T and -1513C alleles, respectively, yield restriction fragments of 174/325 base pairs and 98/401 base pairs, respectively. Because the polymorphisms G-201A and C-1596T are in absolute LD (D= ϭ 1, r 2 ϭ 1, in a validation sample of 188 individuals), we infer the G-201A genotypes from the C-1596T genotypes. The accuracy of genotyping data for each SNP obtained from PCR/restriction fragment length polymorphism analysis was validated by direct sequencing of a 8% masked, random sample of patients.
Functional Analyses In Vitro and In Vivo
We performed electrophoretic mobility shift assays with IFN-␥-(100 ng/mL; BD Pharmingen, San Di-ego, CA) stimulated HepG2 cell nuclear extracts, biotinlabeled oligonucleotide probes corresponding to CXCL10 -201G and -201A alleles (synthesized by Shanghai Sangon Co, Shanghai, China), and LightShift EMSA kit (Pierce, Rockford, IL). The sequences of oligonucleotide probes for G and A alleles were 5=-TAAATAATACCTTC-GAGTCTGCAACAT-3= and 5=-TAAATAATACCTTCAA-GTCTGCAACAT-3=, respectively.
We chose genomic DNAs from haplotype 1/1 and 3/3 (see Supplementary Table 2 ; see supplemental material online at www.gastrojournal.org) homozygotes for reporter construction. DNA fragments corresponding to CXCL10 promoter region from nucleotides -1749 to Ϫ7 and -359 to Ϫ7 (relative to the first nucleotide of open reading frame of CXCL10 gene) were amplified and cloned into pGL3-enhancer vectors (Promega, Madison, WI). The sequences of all reporter constructs were verified by direct sequencing. IFN-␥-(100 ng/mL; BD Pharmingen) stimulated HepG2 cells (2 ϫ 10 5 ) were transfected with 500 ng of one of the constructs together with 20 ng pRL-TK vector (Promega), an internal control for transfection efficiency, using JetPEI transfection reagent (PolyPlus-transfection Co, Illkirch, France). After 26 hours, cells were collected and their luciferase activities were measured using the Dual-Luciferase Reporter Assay system (Promega). The relative luciferase levels were obtained from 3 independent experiments performed in quadruplicate.
HBV-naive umbilical blood mononuclear cells from newborn infants were stimulated with IFN-␥ (100 ng/mL; BD Pharmingen). The CXCL10 G-201A genotypes of their genomic DNAs were determined by PCR/restriction fragment length polymorphism. Chromatin immunoprecipitations (ChIPs) were conducted on 5 heterozygous samples with monoclonal antibody against the Ser5 phosphorylated CTD of RNA polymerase II (MMS-134R clone H14; Covance, Princeton, NJ) as described previously. 20 Quantitative allelic discrimination of the ChIP-isolated genome fragments was performed using Opticon Monitor 2 (MJ Research [BioRad, Hercules, CA]) with MGB-TaqMan probes corresponding to -201A and -201G alleles. RNAs of IFN-␥-(100 ng/mL; BD Pharmingen) stimulated peripheral blood mononuclear cells from adult blood donors were extracted by TriPure reagent (Roche, Basel, Switzerland). We performed real-time quantitative PCR using Opticon Monitor 2 (MJ Research) with MGB-TaqMan probes corresponding to CXCL10 and ␤-actin messenger RNAs. Relative quantification with MGB-TaqMan probes was performed by the 2 -Ct method as described previously. 21 Primers and MGB-TaqMan probes used above are listed in Supplementary  Table 3 (see supplemental material online at www.gastrojournal.org). All probes and primers were synthesized by GeneCore BioTechnologies Co (Shanghai, China), and the MGB-TaqMan probes were authorized by Applied Biosystems (Foster City, CA).
We examined serum CXCL10 levels in HBV carriers with human Quantikine CXCL10 Immunoassay kit (R&D Sys-tems, Minneapolis, MN). Immunohistochemistry was performed to assess CXCL10 expression in the liver tissues of HBV carriers. Liver tissues were fixed in 4% buffered formaldehyde and embedded in paraffin. We used goat polyclonal anti-human CXCL10 immunoglobulin G (R&D Systems) and peroxidase-conjugated immune polymer reagents (Envision Plus Kit, Dako, Carpinteria, CA) for immunohistochemistry according to the manufacturer's instructions.
Statistical Analysis
Statistical analysis was performed using SPSS software (version 9.0; SPSS Inc, Chicago, IL). Allele frequencies for each SNP were determined by gene counting. 2 tests were used to examine the differences in allele frequencies and genotype distributions between groups. Multivariable logistic regression analysis was performed to adjust risk factors (such as age, sex, and alcohol use). The association between genotyped polymorphisms and risk of disease was estimated by P values, odds ratios (ORs), and 95% confidence intervals (95% CIs). Student t tests were used to analyze the results of luciferase reporter assays, allele-specific ChIPs, and relative messenger RNA expressions. Oneway analysis of variance (ANOVA) method was used to analyze serum levels of CXCL10 between patient groups. A P value of less than .05 was considered significant.
Results
Sequence Variations in CXCL10 Genomic Region
Resequencing of the 4228 base pairs of the CXCL10 genomic region in the 27 samples (54 chromosomes) revealed 21 SNPs (Table 1 and Figure 1A ), including 8 novel SNPs (2, 9, 10, 11, 13, 16, 20, and 21) . None of the SNPs were in the coding region. No multiple-base insertion/deletion or short-tandem repeat variation was found. Pairwise LD measures (D= and r 2 ) are diagrammatically illustrated in Figure 1B . LD analysis showed that there was absolute LD (D= ϭ 1, r 2 ϭ 1) among the SNPs 1, 3, 5, 6, 7, 12, 13, 14, 15, 17, 18, 19, 20 , and 21 and between the SNPs 2 and 11. Eight haplotypes were identified, among which 3 were with frequencies more than 10% (see Supplementary Table 2 ). Three SNPs (1, 4, and 11, ie, Del -1767T, C-1513T, and G-201A polymorphism, respectively), which captured more than 93% of the haplotype diversity observed within the gene region, were determined as htSNPs.
Because the no. 1 SNP (Del -1767T) has a very low frequency in the Chinese Han population (T allele frequency is 0.021, which was validated in 96 progressive carriers and 96 nonprogressive carriers), according to the common variant common diseases hypothesis, 22 it is unfit for genotyping analysis in a genetic association study. We selected the other 2 htSNPs as genetic markers for subsequent genotyping analysis; one was C-1513T (ie, SNP 4), which had the highest allele frequency, and the other was G-201A (ie, SNP 2), which had moderate variation frequency and was located between the nuclear factor B1 and nuclear factor B2 binding sites in the promoter region of the CXCL10 gene. 23
Case-Control Study
The selected characteristics and genotype distributions of the C-1513T and G-201A in naive controls, nonprogressed carriers, and progressed carriers are summarized in Table 2 . The genotype distributions for the 2 SNPs were in Hardy-Weinberg equilibrium in each group. Although an effort was made to obtain a good match on age and sex between progressed and nonprogressed carriers, progressed carriers were older (P Ͻ .001) and consisted of more men (P Ͻ .001) than nonprogressed carriers in our hospital-based case-control populations. The difference in alcohol consumption status (P Ͻ .001) between progressed and nonprogressed carriers may be due to a sex difference, because few women drink in China.
There was no significant difference in allele frequencies or genotype distributions of C-1513T between nonprogressed and progressed carriers from Beijing (P ϭ .624) and Chongqing region (P ϭ .858). However, we observed an elevated frequency of -201A allele in progressed carriers. The -201A allele frequency was significantly higher in progressed carriers than in nonprogressed carriers in Table 4 ). However, the association was not significant in female patients (P ϭ .162 in the whole population and P ϭ .095 in individuals who have known parents or siblings for chronic HBV carriers).
Regulatory Effects of G-201A Polymorphism in the Promoter of CXCL10
We used electrophoretic mobility shift assays to determine if the genomic DNA sequences containing each allele of G-201A interact differentially with nuclear protein extracts from HepG2 cell lines. The intensity of binding band was higher for the -201A allele than for the -201G allele (Figure 2A ). The binding of each probe was competed by the same 200-fold unlabeled oligonucleotides (corresponding cold probes), supporting the specificity of nuclear protein binding. We next cloned genomic regions from nucleotides -359 to Ϫ7 and nucleotides -1749 to Ϫ7 of CXCL10 promoter into pGL3-Enhancer vectors ( Figure 2B ). Genomic DNAs from haplotype 1/1 and 3/3 homozygotes were chosen for reporter construction (see Supplementary Table 2 ). The inserted sequences of all reporter constructs were identical except nucleotides at position -201 and -1596. The pGL3-Enhancer-201G constructs showed 1.7-fold lower luciferase expression than the pGL3-Enhancer-201A constructs (t test; P ϭ .003), and the pGL3-Enhancer-1596C-201G haplotype constructs showed 2.3-fold lower luciferase expression than the pGL3-Enhancer-1596T-201A haplotype constructs (t test; P Ͻ .001). These results suggest that the disease-susceptible haplotype -1596T-201A is crucial for regulation of CXCL10 expression. NOTE. Total numbers for each polymorphism vary because not all samples were successfully genotyped. The genotype distribution in each group was in Hardy-Weinberg equilibrium. "Drinker" was defined as alcohol consumption of Ն40 g/wk for men and Ն20 g/wk for women, which included occasional drinkers and daily drinkers. a P values were for the comparison between progressed and nonprogressed HBV carriers; for sex, age, and alcohol consumption, P values were given by univariate logistic analysis; for the CXCL10 polymorphisms, P values were given by 2 tests. b Individuals who have known parent(s) or sibling(s) who are chronic HBV carriers (indicates early infection before childhood).
Next, we identified IFN-␥-stimulated heterozygous umbilical blood mononuclear cell samples (with respect to the G-201A) of 5 HBV-naive newborn infants and quantified relative phosphorylated RNA Pol II loading on the 2 alleles by ChIPs followed with MGB-TaqMan-based allelic discrimination method. Figure 2C displays the mean -201A to -201G allele ratios obtained from quantitative genotyping (in triplicate) of the unprecipitated cell lysate samples (input) and the DNA fragments from 3 parallel RNA Pol II ChIP experiments (output). The mean immunoprecipitated -201A to -201G allele ratio was 3.29 (t test; P ϭ .001). We also quantified expression of CXCL10 in IFN-␥-stimulated peripheral blood mononuclear cells from healthy donors. The mean CXCL10/␤-actin transcript ratio from individuals with -201A allele (-201A/A genotype [n ϭ 3] and -201G/A genotype [n ϭ 5]) was 2.56-fold higher than that from individuals with -201G/G genotype (n ϭ 10) (t test; P ϭ .008; Figure 2D ). Figure 3A and B shows the dynamic changes of serum CXCL10 levels in HBV carriers affected with moderate hepatitis B ( Figure 3A) and liver cirrhosis-based acuteon-chronic liver failure ( Figure 3B) ; the serum CXCL10 levels varied with the increase and decrease of serum alanine aminotransferase levels. There was no significant difference in serum CXCL10 levels among 3 genotypes of G-201A ( Figure 3C ) and between men and women ( Figure 3D ) both in progressed and nonprogressed carriers. Significantly increased levels of serum CXCL10 were observed in progressed carriers as compared with nonprogressed carriers (Figure 3E ; one-way ANOVA test; P Ͻ .0001). Among progressed carriers, patients with severe hepatitis B had significantly higher serum CXCL10 levels than those with liver cirrhosis or hepatocellular carcinoma ( Figure 3E ; one-way ANOVA test; P ϭ .002 and P ϭ .041, respectively). We detected serum IFN-␥ levels to equilibrate the serum CXCL10 levels in each sample; however, all samples were negative for IFN-␥.
CXCL10 Levels in Serum and Liver Tissues of HBV Carriers
The immunohistochemical staining results revealed that CXCL10 did express in HBV carriers with chronic hepatitis B ( Figure 4B and F) , severe hepatitis B ( Figure 4C) , and liver cirrhosis with acute-on-chronic liver failure ( Figure 4D and E) but not in HBV carriers with normal liver ( Figure 4A ). Strong CXCL10 staining was detected in the cytoplasm of hepatocytes but not in other cell types throughout the sections, and the most intense staining was observed near areas with lymphoid infiltration.
Discussion
In this study, we found that the -201A allele carriers (-201G/A and -201A/A genotypes) of the G-201A polymorphism, which was located at the promoter region of the CXCL10 gene, were associated with increased susceptibility to disease progression in male HBV carriers. The G-201A polymorphism alters the binding affinity of nuclear protein and regulates CXCL10 expression. We also observed that the disease-susceptible genotypes, -201G/A and -201A/A, have higher CXCL10 transcription levels in IFN-␥-stimulated peripheral blood mononuclear cells compared with the -201G/G genotype. Further, the enzyme-linked immunosorbent assay and immunohistochemical analyses showed increased CXCL10 production in serum and liver tissues in progressed HBV carriers. To our knowledge, this is the first report that the naturally occurring genetic variants of the CXCL10 gene may determine an individual's susceptibility to chronic HBV infection. Several association studies have revealed that the HLA allele DRB1, 24 TNF-␣, 25 MBP, 26 VDR, 27 and ESR1 14 genes are related to the susceptibility to HBV clearance or persistence. Other clinical outcomes, such as disease severity or progression, may also be influenced by host genetics, but there is much less evidence supporting this theory. 28 Recently, Chong et al 29 demonstrated the lowexpression promoter haplotypes of MBL associated with the occurrence of cirrhosis and hepatocellular carcinoma in progressed HBsAg carriers. Although the highly significant association between CXCL10 and susceptibility to disease progression of chronic HBV infection derives from biologically based a priori hypothesis, our initial findings should be independently verified in populations of different ancestry, such as white and African populations. We resequenced the CXCL10 genomic region in 48 whites and 48 Africans, and the allele frequencies of -201A allele were 0.042 and 0.021, respectively. It should be mentioned that C-1596T and G-201A were in absolute LD in whites but not in Africans. According to the famous "out of Ethiopia" theory, 30 the -1596T-201A haplotype may be an ancient variant and be under selection in human evolution. We indeed observed positive selection of CXCL10 gene in whites (our unpublished data, June 2005). The mean age of our nonprogressed carriers was lower than that of the progressed carriers; hence, we have controlled for the effect of age and sex in all analyses by logistic regression. Moreover, we compared the mean age of patients with different CXCL10 G-201A genotypes, no significant differences were found among CXCL10 G-201A genotypes in both progressed and nonprogressed carriers (data not shown). To decrease the bias of age on the effect estimates, we conducted stratification analysis for age and sex. Interestingly, the association remained significant both in patients younger than 40 years (P ϭ .002) and patients 40 years and older (P ϭ .026). The -201A allele frequency does not increase along with the age in both progressed and nonprogressed HBV carriers. This is in line with our observation that the CXCL10 -201A allele is associated with disease progression in HBV carriers. Also, the lower percentage of hepatitis B e antigen (HBeAg) seropositivity in progressed carriers was probably attributable to the effect of age, because HBeAg seroconversion would occur with aging. Although an effort was made to obtain a good match on age and sex between cases and controls, this was not fulfilled in our hospital-based case-control study. We realize that the ideal model for disease progression in HBV carriers is a community-based, long-term cohort study. From this initial population at present, an HBV carrier cohort will be established, and time-to-progression ("survival") type analysis should be conducted in the future.
There was a gender difference between the G-201A polymorphism and disease progression in the whole population or in patients with known parent or sibling carriers. The lack of significant association in the female population may be due to the decreased sample size of female carriers because there are only 183 female progressed carriers. An alternative explanation is that the IFN-␥/CXCL10 response was influenced by gonadal steroids. Recently, Cernetich et al 31 reported that gonadally intact female patients exhibited higher expression of IFN-␥ and CXCL10 than did intact male and gdx female mice during peak parasitemia and proposed that IFN-␥ may be the primary mediator of sex differences in response to blood-stage malaria infection. Large-sized female HBV carriers should be recruited to verify the association between the G-201A polymorphism and disease progression of HBV carriers in the future.
The importance of the IFN-␥/tumor necrosis factor ␣ pathway for the clearance of HBV and liver injury has recently been emphasized. 7, 9, 32 Preliminary data from mice, 8 chimpanzees, 9 and humans 12, 13, 33 have shown relevance between CXCL10 expression and several types of liver diseases. The allelic differences of nuclear protein binding, luciferase reporter transcriptional activity, and immunoprecipitated RNA Pol II loading at G-201A locus suggest that this novel polymorphism can affect CXCL10 gene expression. We showed that the CXCL10 protein level is elevated in sera and livers of progressed HBV carriers, and the -1596T-201A haplotype is associated with higher CXCL10 transcription in IFN-␥-stimulated peripheral blood mononuclear cells, therefore providing in vivo functional evidence of association of this risky variant. Augmented CXCL10 molecules in hepatocytes chemoattract activated T lymphocytes and natural killer cells to liver parenchyma; this led to chronic liver inflammation, which correlated with severe hepatitis, liver fi- The magnitude of difference of luciferase activity between the 2 promoter alleles is not as large in the short promoter experiment as it is in the longer promoter experiment; this may be due to the effects of different insertion length on the topological structure or other complex mechanisms of the reporter plasmids. There are some limitations in our reporter assays. Our results just show the different functional effect of -1596T-201A haplotype, and the contribution of the C-1596T polymorphism cannot be completely excluded and needs to be ascertained in the future.
Of the 1147 progressed carriers, 241 individuals were patients with severe hepatitis B and without evidence of liver cirrhosis or hepatocellular carcinoma. This subgroup can be used as a control group to analyze the association with hepatitis B per se. The association is also significant in patients with severe hepatitis (adjusted OR, 1.64; P ϭ .004; data not shown). We did observe significant elevation of serum CXCL10 levels and hepatocyte CXCL10 expression during chronic hepatitis B, from patients with mildly abnormal alanine aminotransferase levels (liver inflammation) to patients undergoing acute liver failure (liver necrosis). From Figure 3A and B, we can observe that the serum CXCL10 level dynamically correlated with hepatitis B (liver inflammation) per se rather than the presence of severe liver disease.
Some limitations may hinder the comparison of serum CXCL10 levels between the 3 genotypes or between men and women. First, the -201A/A homozygotes are rare in each subgroup; it may reduce the statistical power to detect the differences. Second, the serum CXCL10 levels should be equilibrated on serum IFN-␥ levels; however, we did not detect any serum IFN-␥ in patients' sera (data not shown). Third, the time points at serum collection may correspond to diverse liver inflammatory response phases in patients. Further studies should concern the correlation between serum CXCL10 levels and liver CXCL10 messenger RNA expression, liver CXCL10 and IFN-␥ messenger RNA expression, or CXCL10 production and liver histopathologic score.
In conclusion, we identified that a regulatory SNP, G-201A in the promoter region of CXCL10, was associated with susceptibility to disease progression of chronic HBV infection. More steps are required before the importance of the CXCL10 gene in disease progression of chronic HBV infection can be fully ascertained. First, data from other populations are needed to confirm our initial observation. Second, the signal pathway of the novel regulatory G-201A polymorphism in the CXCL10 gene and its functional influence on clinical consequences of liver diseases, such as hepatitis B, hepatitis C, liver cirrhosis, and autoimmune hepatitis, should be further identified.
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